A novel anti‑EGFR monoclonal antibody (EMab‑17) exerts antitumor activity against oral squamous cell carcinomas via antibody‑dependent cellular cytotoxicity and complement‑dependent cytotoxicity
Junko Takei(Tohoku University), Yukinari Kato(Tohoku University)
Cited by 22
Related Papers
Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors
|Journal of Biological Chemistry|2003|266
A defucosylated anti‑CD44 monoclonal antibody 5‑mG2a‑f exerts antitumor effects in mouse xenograft models of oral squamous cell carcinoma
|Oncology Reports|2020|46
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma
|Oncotarget|2018|45
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
|Oncology Letters|2020|41
Antitumor activities of a defucosylated anti‑EpCAM monoclonal antibody in colorectal carcinoma xenograft models
|International Journal of Molecular Medicine|2023|39